Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Rehabilitation of Conversion Gait Disorder

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2011 by Oslo University Hospital.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Norwegian School of Sport Sciences
Information provided by (Responsible Party):
Annika A. Jordbru, Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01422278
First received: January 16, 2006
Last updated: August 22, 2011
Last verified: August 2011

January 16, 2006
August 22, 2011
September 2007
September 2010   (final data collection date for primary outcome measure)
Change in gait patterns [ Time Frame: three weeks ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01422278 on ClinicalTrials.gov Archive Site
Improved life quality [ Time Frame: 12 months ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Rehabilitation of Conversion Gait Disorder
Patients With Conversion Gait Disorder - Effect on Treatment and Common Gait Patterns. Randomized Clinical Trial

Evaluating the effects in functional status after three weeks of cognitive - and behavioural rehabilitation on patients with gait disorder. The patients are followed up as after 1 and 12 months to study if any improvement is still present. The patients are being recruited from neurological units. The intervention is explanation of symptoms, positive reinforcement of normal behaviour and absence reinforcement of dysfunctional behaviour. In addition the study aims at describing typical gait patterns at patients with gait disorder by using biomechanical measurements (EKG).

Patients are being recruited from neurological unit/ div and out patients department of SSR and are randomized to treatment or control group. Essential gait disorders do to conversion symptoms and willingness to participate in either of the two groups with informed consent are required.

Interventional
Phase 1
Phase 2
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Conversion Disorder
Other: Rehabilitation
Three weeks of rehabilitation in Hospital.
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
60
December 2011
September 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • To determine the changes in functional status after three weeks of multidisciplinary rehabilitation in patients with conversion walking disorder.

Exclusion Criteria:

  • Essential gait disorders do to conversion symptoms and willingness to participate in either of the two groups with informed consent are required.
Both
18 Years to 69 Years
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
NCT01422278
2.2004.164, SSR.2005.1
Yes
Annika A. Jordbru, Oslo University Hospital
Oslo University Hospital
Norwegian School of Sport Sciences
Study Chair: Georg Høyer, DH National committees for research ethics in Norway" for REK
Oslo University Hospital
August 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP